Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Cue Biopharma Inc (CUE)

Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Nov 29, 3:30PM CST

CUE : 1.0100 (-0.98%)
Cue Biopharma to Present at Piper Sandler 36th Annual Healthcare Conference on Clinical and Strategic Updates Quiver Quantitative, Inc. - Mon Nov 25, 5:20PM CST

Cue Biopharma will discuss clinical updates and business strategies at the Piper Sandler Healthcare Conference on December 4, 2024.Quiver AI SummaryCue Biopharma, Inc., a clinical-stage biopharmaceutical...

CUE : 1.0100 (-0.98%)
Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Mon Nov 25, 7:00AM CST

CUE : 1.0100 (-0.98%)
Cue Biopharma, Inc. Reports Third Quarter 2024 Business and Financial Update, Highlighting Positive Phase 1 Trial Data for CUE-101 and CUE-102 Quiver Quantitative, Inc. - Fri Nov 15, 1:20AM CST

Cue Biopharma reported positive Phase 1 trial data for CUE-101 and CUE-102, highlighting advancements in T cell modulation therapies.Quiver AI SummaryCue Biopharma, Inc. provided a business and financial...

CUE : 1.0100 (-0.98%)
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights GlobeNewswire - Thu Nov 14, 3:05PM CST

CUE : 1.0100 (-0.98%)
Cue Biopharma Announces Strategic Organizational Transition GlobeNewswire - Thu Nov 14, 7:00AM CST

CUE : 1.0100 (-0.98%)
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference GlobeNewswire - Tue Nov 12, 7:00AM CST

CUE : 1.0100 (-0.98%)
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting GlobeNewswire - Fri Nov 8, 12:30PM CST

CUE : 1.0100 (-0.98%)
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting GlobeNewswire - Fri Oct 4, 8:00AM CDT

CUE : 1.0100 (-0.98%)
Cue Biopharma Reports Second Quarter 2022 Financial Results Globe Newswire - Thu Aug 4, 2022

BOSTON, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...

CUE : 1.0100 (-0.98%)

Barchart Exclusives

How To Profit From The Latest Corporate Spinoffs: A Guide For Investors In 2025 Barchart - Sun Dec 22, 4:00PM CST
How to navigate corporate spinoffs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot